Although nesiritide (recombinant human BNP) was approved for the management of acute decompensated HF, the following ASCEND-HF (A Study Testing the Effectiveness of Nesiritide in Patients with Acute Decompensated Heart Failure) trial did not show any clinical advantages [140]. The gene discussed is NPPB; the disease is hydrops fetalis.